N-acetylcysteine reduces serum creatinine, blood urea nitrogen, symmetric dimethylarginine and urine protein to creatinine ratio in cats with chronic kidney disease: a double-blind, placebo-controlled clinical trial
The incorporation of NAC into treatment regimens demonstrates potential as a treatment strategy for cats with acute-on-chronic kidney disease.
Authors
- Doğukan Özen (ORCID: https://orcid.org/0000-0003-1943-2690)
- Ali Evren Haydardedeoğlu (ORCID: https://orcid.org/0000-0002-8473-0072)
- Ekrem Çağatay ÇOLAKOĞLU (ORCID: https://orcid.org/0000-0003-2789-035X)
- Hadi Ali̇hossei̇ni̇
Institutions
- Aksaray University (TR)
- Ankara University (TR)
- Turkish Society of Hematology (TR)
Publication Details
- Journal
- BMC Veterinary Research
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1186/s12917-026-05328-8
- Primary Topic
- Veterinary Medicine and Surgery
- Type
- article
- Field-Weighted Citation Impact
- 0.00